The Hirshberg Foundation is excited to announce that Dr. Jon King will be joining us at the 19th Annual Symposium on Pancreatic Cancer to discuss the evolving nature of surgical treatments for pancreatic cancer.
Surgery is a cornerstone of treatment for pancreatic cancer that has not spread outside of the primary (main) tumor. While surgery to remove most pancreatic tumors is complex and has historically been associated with poor outcomes, improvements in pancreatic surgery in the past 40 years have made surgery reliably safe for nearly all patients. More recent advances have brought minimally-invasive techniques, complex vascular (blood vessel) resection/reconstruction, and enhanced recovery after surgery into routine clinical use. These, along with effective chemotherapies that are frequently applied before surgery, means that more and more patients are candidates for surgery today than ever before.
Dr. Jonathan King is an Associate Professor in the Division of General Surgery at UCLA. He attended the University of Maryland for his M.D. degree before coming to UCLA for his general surgery residency. After residency, Dr. King spent two years in Pittsburgh, PA (UPMC) for a surgical oncology fellowship before returning to Los Angeles to join the surgery faculty. He is board certified in General Surgery as well as Complex Surgical Oncology and has particular interest in pancreatic cancer and disseminated peritoneal malignancies. He has expertise in robotic-assisted minimally invasive pancreas surgery and performed UCLA’s first minimally-invasive pancreaticoduodenectomy (Whipple procedure). He also started UCLA’s program for hyperthermic intraperitoneal chemoperfusion (HIPEC).
In addition to his clinical interests Dr. King has authored numerous peer-reviewed manuscripts and abstracts as well as book chapters in some of the authoritative surgical textbooks. Dr. King is an enthusiastic surgical educator and is developing the UCLA residency training curriculum for robotic-assisted surgery and he is a member of numerous professional societies.
A valuable presentation for our pancreatic cancer community; we are so happy to have Dr. King present the Surgical Treatment of Pancreatic Cancer: A Moving Target at the 19th Annual Symposium.
